BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2124501)

  • 21. High-dose medroxyprogesterone acetate plus mitomycin-C or vindesine in the treatment of advanced breast cancer.
    Falkson CI; Falkson HC; Falkson G
    Am J Clin Oncol; 1988 Aug; 11(4):431-4. PubMed ID: 2970218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitomycin C and vinblastine in the treatment of advanced breast cancer.
    Radford JA; Knight RK; Rubens RD
    Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1475-7. PubMed ID: 3938396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An aggressive, sequential combination chemotherapy regimen in the treatment of metastatic colorectal carcinoma.
    Beck TM; Hart NE; Woodard DA; Smith CE
    Prog Clin Biol Res; 1986; 216():399-405. PubMed ID: 3088599
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chemotherapy of breast cancers. Coordinated evolution of therapeutic schemes from 1975 to 1985].
    Chauvergne J; Durand M; Mauriac L; Hoerni B; David M
    Rev Fr Gynecol Obstet; 1986 Mar; 81(3):119-22. PubMed ID: 3085195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination chemotherapy in the treatment of advanced squamous cell carcinoma of the uterine cervix.
    Chander S; Ghosh D; Aggarwal N
    Indian J Cancer; 1986 Mar; 23(1):43-8. PubMed ID: 2434412
    [No Abstract]   [Full Text] [Related]  

  • 26. A phase II trial of mitomycin C and 5-fluorouracil as second-line therapy in advanced breast cancer.
    O'Brien ME; Bayliss EJ; Stewart ME; Smyth JF; Rodger A; Leonard RC
    Cancer Chemother Pharmacol; 1990; 27(1):79-80. PubMed ID: 2123134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of advanced breast cancer with two doxorubicin-containing regimens.
    Harris MA; Byrne PJ; Smith FP; Ueno W; Schlesinger C; Oishi S; Schein PS
    Am J Clin Oncol; 1984 Feb; 7(1):51-8. PubMed ID: 6421145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combination chemotherapy with mitomycin C, methotrexate, and vincristine (MMV) for metastatic breast cancer refractory to adriamycin].
    Nomura Y; Kanda K; Tashiro H; Hamada Y; Saeki K
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):824-8. PubMed ID: 6411002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Fluorouracil and mitomycin C in advanced breast cancer.
    Aspegren K; Landberg T
    Radiother Oncol; 1986 Jun; 6(2):121-6. PubMed ID: 3090650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitomycin C in advanced breast cancer.
    Lenaz L
    Cancer Treat Rev; 1985 Dec; 12(4):235-49. PubMed ID: 3938680
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemotherapy for advanced and/or recurrent cervical cancer.
    Lahousen M; Pickel H; Tamussino K
    Arch Gynecol; 1987; 240(4):247-52. PubMed ID: 2440389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination chemotherapy with mitomycin C, vindesine and melphalan for refractory metastatic breast cancer.
    Rausa L; Russo A; Gebbia V; Gebbia N; D'Alessandro N; Palmeri S
    J Cancer Res Clin Oncol; 1991; 117(3):266-8. PubMed ID: 1709643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy with mitomycin-C, epidoxorubicin and vinblastine in CMF failing breast cancer patients.
    Pronzato P; Amoroso D; Bertelli G; Queirolo P; Sertoli MR; Rosso R
    Anticancer Res; 1990; 10(6):1743-5. PubMed ID: 2126683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bleomycin, vincristine, and mitomycin C (BOM) as second-line treatment after failure of cis-platinum-based combination chemotherapy for recurrent cervical cancer.
    Wheelock JB; Krebs HB; Goplerud DR
    Gynecol Oncol; 1990 Apr; 37(1):21-3. PubMed ID: 1691126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitomycin-C and vinblastine in advanced breast cancer.
    Navarro M; Bellmunt J; Balañá C; Colomer R; Jolis L; del Campo JM
    Oncology; 1989; 46(3):137-42. PubMed ID: 2497417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Salvage chemotherapy with mitomycin C and vindesine in metastatic carcinoma of the breast].
    Ardizzoni A; Lionetto R; Repetto L; Pronzato P; Rosso R
    G Ital Chemioter; 1985; 32(1):61-2. PubMed ID: 3938418
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chemotherapy of a patient with FIGO stage IV vulvar cancer with bleomycin, vincristine, mitomycin C, and cisplatin].
    Shimizu Y; Hasumi K; Yagi H; Nakayama K; Chen JT; Hirai Y; Hamada T; Fujimoto I; Yamauchi K; Masubuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):609-12. PubMed ID: 2474044
    [No Abstract]   [Full Text] [Related]  

  • 38. Vindesine and mitomycin C in chemotherapy: refractory advanced breast cancer.
    Di Costanzo F; Gori S; Tonato M; Buzzi F; Crino L; Grignani F; Davis S
    Cancer; 1986 Mar; 57(5):904-7. PubMed ID: 3002594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy for patients with advanced carcinoma of the cervix: trial of mitomycin-C, vincristine, bleomycin, and cisplatin.
    Giannone L; Brenner DE; Jones HW; Greco FA; Burnett LS
    Gynecol Oncol; 1987 Feb; 26(2):178-82. PubMed ID: 2433196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination chemotherapy for metastatic urinary bladder cancer with 5-FU, vincristine, bleomycin, cyclophosphamide, mitomycin, and methotrexate.
    Kubota Y; Shuin T; Miura T; Moriyama M; Fukushima S; Shiozaki H; Ooshima H
    Cancer Treat Rep; 1984 Sep; 68(9):1167-8. PubMed ID: 6206946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.